GMP 세포치료용 소모품 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global GMP cell therapy consumables market size is expected to reach USD 194.66 Million in 2034 from USD 20.01 Million in 2025, growing at a CAGR of 28.76% during 2026-2034.This market is expanding as pharmaceutical companies, biotechnology firms, and research institutions increase the development and manufacturing of cell-based therapies under controlled quality standards. GMP cell therapy consumables include culture vessels, bags, filters, tubing, connectors, media containers, and other single-use products required during cell processing. The growing pipeline of cell therapies is increasing demand for reliable and sterile consumables that can support consistent manufacturing. Greater emphasis on contamination control and process reproducibility is also encouraging adoption of specialized GMP-grade products.

Single-use technologies are an important growth driver because they can reduce cleaning requirements and cross-contamination risks compared with certain reusable systems. Cell therapy manufacturers increasingly require consumables that are compatible with closed or automated processing workflows. Demand is also supported by the expansion of contract development and manufacturing organizations, which provide cell-processing capabilities to therapy developers. Suppliers are developing more specialized components for cell expansion, harvesting, filtration, storage, and cryopreservation as manufacturing processes become increasingly sophisticated.

Future prospects are linked to the continued development of cell therapies and the transition toward scalable commercial manufacturing. Automated cell-processing systems are likely to increase demand for preassembled and application-specific consumable sets. Manufacturers may also focus on improved material compatibility, traceability, sterility assurance, and supply reliability. As developers move therapies from research and clinical stages toward commercial production, the requirement for standardized GMP-compatible consumables should increase. Supply-chain resilience and regulatory compliance will remain important factors influencing purchasing decisions across the sector.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

• Cell Culture Media and Supplements
• Cell Separation and Purification Consumables
• Cryopreservation Consumables
• Cell Transduction Consumables
• Other Consumables (Labware, Bioreactors, etc.)

By Cell Type

• Stem Cells (Embryonic, Induced Pluripotent, Adult)
• T-Cells
• Natural Killer (NK) Cells
• Other Cell Types (Dendritic Cells, Chondrocytes, etc.)

By Application

• Oncology
• Regenerative Medicine
• Neurology
• Cardiovascular
• Immunology
• Other Applications

By End User

• Biopharmaceutical Companies
• Contract Manufacturing Organizations (CMOs)
• Academic and Research Institutions
• Hospitals and Clinics
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific Inc., Lonza Group, Merck KGaA, Corning Inc., Sartorius AG, Miltenyi Biotec, STEMCELL Technologies Inc., Takara Bio Inc., Bio-Techne Corporation, HiMedia Laboratories, Avantor Inc., Beckman Coulter Inc., Terumo BCT Inc., Roche Diagnostics, Fujifilm Irvine Scientific Inc., CellGenix GmbH

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GMP CELL THERAPY CONSUMABLES MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Cell Culture Media and Supplements Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Cell Separation and Purification Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cryopreservation Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Cell Transduction Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Consumables (Labware, Bioreactors, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GMP CELL THERAPY CONSUMABLES MARKET: BY CELL TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Cell Type
• 5.2. Stem Cells (Embryonic, Induced Pluripotent, Adult) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. T-Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Natural Killer (NK) Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Other Cell Types (Dendritic Cells, Chondrocytes, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GMP CELL THERAPY CONSUMABLES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Regenerative Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Cardiovascular Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GMP CELL THERAPY CONSUMABLES MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Biopharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Contract Manufacturing Organizations (CMOs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Academic and Research Institutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Hospitals and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GMP CELL THERAPY CONSUMABLES MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Cell Type
  • 8.2.3 By Application
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Cell Type
  • 8.3.3 By Application
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Spain
  • 8.3.10 Russia
  • 8.3.11 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Cell Type
  • 8.4.3 By Application
  • 8.4.4 By End User
  • 8.4.5 China
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 India
  • 8.4.9 Australia
  • 8.4.10 South East Asia
  • 8.4.11 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Cell Type
  • 8.5.3 By Application
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Cell Type
  • 8.6.3 By Application
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL GMP CELL THERAPY CONSUMABLES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific Inc
  • 10.2.2 Lonza Group
  • 10.2.3 Merck KGaA
  • 10.2.4 Corning Inc
  • 10.2.5 Sartorius AG
  • 10.2.6 Miltenyi Biotec
  • 10.2.7 STEMCELL Technologies Inc
  • 10.2.8 Takara Bio Inc
  • 10.2.9 Bio-Techne Corporation
  • 10.2.10 HiMedia Laboratories
  • 10.2.11 Avantor Inc
  • 10.2.12 Beckman Coulter Inc
  • 10.2.13 Terumo BCT Inc
  • 10.2.14 Roche Diagnostics
  • 10.2.15 Fujifilm Irvine Scientific Inc
  • 10.2.16 CellGenix GmbH